Lacosamide 70069-0471-10
- Manufacturer
- Somerset Therapeutics, Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- October 10, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA214960
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
70069-0471-10Selected10 VIAL, SINGLE-DOSE in 1 CARTON (70069-471-10) / 20 mL in 1 VIAL, SINGLE-DOSE (70069-471-01)